ProPhase Labs, Inc. Quarterly Marketable Securities, Current in USD from Q3 2017 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
ProPhase Labs, Inc. quarterly Marketable Securities, Current history and growth rate from Q3 2017 to Q2 2024.
  • ProPhase Labs, Inc. Marketable Securities, Current for the quarter ending June 30, 2024 was $1K.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $1K* -$5.28M Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $58K -$5.89M -99% Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $3.13M -$5.2M -62.5% Dec 31, 2023 10-Q 2024-08-14
Q3 2023 $2.57M -$1.11M -30.3% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $5.28M +$1.74M +49.2% Jun 30, 2023 10-Q 2023-08-11
Q1 2023 $5.95M +$2.4M +67.8% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 $8.33M -$451K -5.14% Dec 31, 2022 10-K 2024-03-29
Q3 2022 $3.68M -$10.4M -73.9% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $3.54M -$14.6M -80.4% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 $3.54M +$12K +0.34% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 $8.78M +$7.14M +436% Dec 31, 2021 10-K 2023-03-29
Q3 2021 $14.1M +$12.7M +906% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $18.1M +$14.8M +442% Jun 30, 2021 10-Q 2021-08-13
Q1 2021 $3.53M +$2.69M +320% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 $1.64M +$713K +77% Dec 31, 2020 10-K 2022-03-31
Q3 2020 $1.4M -$2.36M -62.7% Sep 30, 2020 10-Q 2020-11-19
Q2 2020 $3.34M -$1.35M -28.7% Jun 30, 2020 10-Q 2020-08-11
Q1 2020 $840K -$3.39M -80.1% Mar 31, 2020 10-Q 2020-05-12
Q4 2019 $926K -$5.76M -86.2% Dec 31, 2019 10-K 2021-03-31
Q3 2019 $3.76M -$3.11M -45.2% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $4.69M -$2.09M -30.9% Jun 30, 2019 10-Q 2019-08-12
Q1 2019 $4.23M -$14.1M -76.9% Mar 31, 2019 10-Q 2019-05-14
Q4 2018 $6.69M -$12.1M -64.4% Dec 31, 2018 10-K 2020-03-26
Q3 2018 $6.87M -$16.8M -71% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 $6.78M Jun 30, 2018 10-Q 2018-08-20
Q1 2018 $18.3M Mar 31, 2018 10-Q/A 2018-08-20
Q4 2017 $18.8M Dec 31, 2017 10-K 2019-03-26
Q3 2017 $23.6M Sep 30, 2017 10-Q/A 2018-08-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.